Xing Yongna, Lin Win, Jiang Mei, Cao Donghui, Myers Rebecca V, Bernard Michael P, Moyle William R
Department of OB-GYN, Robert Wood Johnson (Rutgers) Medical School, Piscataway, New Jersey 08854, USA.
J Biol Chem. 2004 Oct 22;279(43):44427-37. doi: 10.1074/jbc.M406931200. Epub 2004 Aug 9.
Efforts to identify the manner in which human choriogonadotropin (hCG) contacts lutropin receptors (LHR) have been stymied by the complex structure of the hormone and the likelihood that it contacts the receptor at multiple sites. During studies of hCG assembly in mammalian cells, we found that addition of a cysteine to the long disordered beta-subunit COOH terminus (betaCT) enabled it to become cross-linked by a disulfide to cysteines that are substituted for residues in loop alpha2 or in the alpha-subunit COOH terminus (alphaCT). This created a "knob" on the alpha-subunit at the location of the cysteine. Knobs of various sizes and charges were useful for probing surfaces of the alpha-subunit thought previously to contact the LHR. Attachment of the betaCT to residues in loop alpha2 facing loops beta1 and beta3 reduced hormone activity only a few fold revealing that this surface does not participate in essential high affinity receptor contacts, a finding inconsistent with our earlier view of the hCG-LHR complex. In contrast, this approach showed that the opposite surface of loop alpha2 appeared to be nearer the receptor interface. Although attachment of knobs to portions of the alphaCT reduced hormone activity substantially, this finding was difficult to interpret. As discussed, this procedure should be adapted readily to other proteins and may facilitate the introduction of fluorophores, enzymes, or other reagents at specific sites on protein surfaces. It may also permit one to cross-link proteins or to obscure specific protein surfaces during the development of "Trojan Horse" therapeutics.
由于人绒毛膜促性腺激素(hCG)结构复杂且可能在多个位点与促黄体激素受体(LHR)接触,因此确定hCG与LHR接触方式的研究工作受阻。在对哺乳动物细胞中hCG组装的研究过程中,我们发现,在无规则的β亚基长羧基末端(βCT)添加一个半胱氨酸,能使其通过二硫键与取代α2环或α亚基羧基末端(αCT)中残基的半胱氨酸交联。这在α亚基上半胱氨酸所在位置形成了一个“瘤”。各种大小和电荷的“瘤”有助于探测此前认为与LHR接触的α亚基表面。将βCT连接到α2环中面向β1环和β3环的残基上,只会使激素活性降低几倍,这表明该表面不参与关键的高亲和力受体接触,这一发现与我们之前对hCG-LHR复合物的看法不一致。相比之下,这种方法表明α2环的相对表面似乎更靠近受体界面。虽然将“瘤”连接到αCT的部分会大幅降低激素活性,但这一发现难以解释。如前所述,该方法应能很容易地应用于其他蛋白质,并可能有助于在蛋白质表面的特定位点引入荧光团、酶或其他试剂。它还可能使人们在开发“特洛伊木马”疗法的过程中交联蛋白质或遮蔽特定的蛋白质表面。